Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Logo
RARE US​

Ultragenyx Pharmaceutical Inc.(RARE US)

$15.65-0.301.88%Ext:$15.41-0.241.56%(Market Closed · 23:56:08 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials

Income Statement

Balance SheetCash Flow
Millions USD (ex. Per Share)
FY201112/31/2011
FY201212/31/2012
FY201312/31/2013
FY201412/31/2014
FY201512/31/2015
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Revenue434.2560.2673.0669.4
-Cost of Revenue45.276.7109.0110.0
Gross Profit389.0483.5564.0559.4
-Operating Expenses958.21,019.51,099.01,121.2
+Selling, General & Admin309.8321.6349.0350.3
+General And Administrative Expenses---—
+Research and Development648.4697.9750.0770.9
+Other Operating Expenses----
Operating Income-569.2-536.0-535.0-561.8
+Non Operating Income-78.6-58.1-73.0-87.8
+Interest Income, Net-39.3-26.5-37.0-44.0
+Interest Income26.736.525.024.2
-Interest Expense66.063.062.068.2
+Other Non-Op Income-39.3-31.6-36.0-43.8
Pretax Income-608.5-567.6-571.0-605.5
-Income Tax Expense-1.81.64.03.8
Income from Cont Ops-606.6-569.2-575.0-609.4
-Net Extraordinary Losses----
+Discounted operations----
+XO & Accounting Changes----
Income Incl. MI-606.6-569.2-575.0-609.4
-Minority Interests----
Net Income, GAAP-606.6-569.2-575.0-609.4
-Prfrrd Div & Other----
Net Income Avail To Common-606.6-569.2-575.0-609.4
Weighted Average Shs Out73,543,862.090,538,118.098,600,000.0398,731,742.0
EPS-8.3-6.3-5.8-6.1
Weighted Average Shs Out Dil73,543,862.090,538,118.098,600,000.0398,731,742.0
EPS Diluted-8.3-6.3-5.8-6.1